LOC105379103: A Protein Targeted for Drug Development (G105379103)
LOC105379103: A Protein Targeted for Drug Development
LOC105379103 is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the LOC105 family of proteins, which are known for their role in cell signaling and inflammation.
One of the most interesting aspects of LOC105379103 is its potential as a drug target. The LOC105 family of proteins has been shown to play a role in a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Additionally, LOC105379103 has been shown to interact with several key signaling pathways, including the NF-kappa pathway.
NF-kappa is a well-known signaling pathway that is involved in a wide range of cellular processes, including cell growth, differentiation, and inflammation. LOC105379103 has been shown to play a role in the regulation of NF-kappa signaling, which suggests that it may be a potential drug target for a variety of diseases.
One potential way to target LOC105379103 is to use small molecules that can inhibit its activity in the NF-kappa pathway. This could be done through a variety of methods, including inhibition of LOC105379103 itself, or through inhibition of the activity of LOC105379103 in combination with other proteins.
Another approach to targeting LOC105379103 may be to use drugs that specifically target its downstream targets. LOC105379103 has been shown to interact with several proteins, including Focal Adhesion Protein (FAAP), which is a protein that is involved in the regulation of cell adhesion.
FAAP is a protein that is expressed in a wide range of tissues and is involved in the regulation of cell adhesion, as well as other processes, such as cell survival and migration. LOC105379103 has been shown to interact with FAAP, which suggests that it may be a potential drug target for diseases that are characterized by disrupted cell adhesion.
Another potential way to target LOC105379103 is to use drugs that specifically target its structural components. LOC105379103 is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. This suggests that it may have a variety of structural components that could be targeted by drugs.
One potential approach to targeting LOC105379103 is to use antibodies that specifically recognize and target its protein component. This could be done through a variety of methods, including affinity purification, cross-linked antibodies, and yeast two-hybrid assays.
Another potential way to target LOC105379103 is to use drugs that specifically target its downstream chemical modifications. LOC105379103 is a protein that is involved in the regulation of protein stability and localization, as well as other processes, such as post-translational modification (PTM) and protein-protein interaction (PPI).
Post-translational modification (PTM) is a process in which proteins are modified after their synthesis, but before they enter the cytoplasm. PTMs are important for the regulation of protein stability, localization, and interactions with other proteins. LOC105379103 is involved in the regulation of PTM, which suggests that it may be a potential drug target for diseases characterized by disrupted protein stability.
Protein-protein interaction (PPI) is a
Protein Name: Uncharacterized LOC105379103
The "LOC105379103 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC105379103 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
LOC105379105 | LOC105379107 | LOC105379109 | LOC105379117 | LOC105379118 | LOC105379130 | LOC105379133 | LOC105379144 | LOC105379164 | LOC105379168 | LOC105379171 | LOC105379174 | LOC105379176 | LOC105379185 | LOC105379193 | LOC105379232 | LOC105379235 | LOC105379242 | LOC105379243 | LOC105379289 | LOC105379297 | LOC105379314 | LOC105379315 | LOC105379318 | LOC105379341 | LOC105379344 | LOC105379362 | LOC105379365 | LOC105379382 | LOC105379385 | LOC105379395 | LOC105379399 | LOC105379490 | LOC105379514 | LOC105379570 | LOC105379599 | LOC105379614 | LOC105379647 | LOC105379648 | LOC105379652 | LOC105379656 | LOC105379658 | LOC105379660 | LOC105379663 | LOC105379664 | LOC105379665 | LOC105379667 | LOC105379749 | LOC105379857 | LOC105447645 | LOC107983962 | LOC107983963 | LOC107983974 | LOC107983976 | LOC107983981 | LOC107983982 | LOC107983986 | LOC107984003 | LOC107984041 | LOC107984063 | LOC107984079 | LOC107984098 | LOC107984108 | LOC107984113 | LOC107984118 | LOC107984129 | LOC107984137 | LOC107984144 | LOC107984145 | LOC107984146 | LOC107984179 | LOC107984214 | LOC107984221 | LOC107984238 | LOC107984251 | LOC107984256 | LOC107984264 | LOC107984284 | LOC107984314 | LOC107984316 | LOC107984326 | LOC107984361 | LOC107984363 | LOC107984381 | LOC107984390 | LOC107984408 | LOC107984526 | LOC107984530 | LOC107984536 | LOC107984543 | LOC107984558 | LOC107984563 | LOC107984567 | LOC107984576 | LOC107984588 | LOC107984625 | LOC107984626 | LOC107984634 | LOC107984647 | LOC107984654
